Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Uterine sarcoma
Results 1-25 of 38 for your search:
Start Over
Hypofractionated or Single Dose Image-Guided Radiation Therapy in Treating Patients with Metastatic Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 10-154, NCI-2010-02150, NCT01223248
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients with High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0277, NCI-2012-00249, CDR0000724874, IRCI 001, NCT01533207
Surgery or Non-surgical Management in Treating Patients with Intra-abdominal Cancer and Bowel Obstruction
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: S1316, NCI-2014-01497, SWOG/S1316, NCT02270450
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Aerosolized Aldesleukin in Treating Patients with Lung Metastases
Phase: Phase II, Phase I
Type: Treatment
Age: 12 and over
Trial IDs: 2010-0700, NCI-2012-00788, NCT01590069
PI3K Inhibitor BKM120 in Treating Patients With Refractory Advanced Solid Tumors That Have PIK3CA Mutations
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-211, NCI-2012-00257, NCT01501604
Alisertib in Treating Patients with Advanced or Metastatic Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A091102, NCI-2012-01991, CALGB-A091102, CDR0000737403, NCT01653028
Psychosexual Intervention in Patients With Stage I-III Gynecologic Cancer
Phase: Phase II
Type: Supportive care
Age: 21 to 80
Trial IDs: OSU-10077, NCI-2012-01341, 2010C0088, NCT01764802
Nivolumab in Treating Patients with Advanced Uterine Leiomyosarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9672, NCI-2014-02403, NCT02428192
Randomized Clinical Trial of Skin Closure with Staples versus Suture in Reducing Complications after Surgery in Patients with BMI of 30 or Greater
Phase: Phase II
Type: Supportive care
Age: 18 to 85
Trial IDs: 201304058, NCI-2013-01279, NCT01977612
Z-endoxifen Hydrochloride in Treating Patients with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0061, NCI-2013-01475, 110061, P10725, 8826, NCT01273168
Pazopanib Hydrochloride and Abexinostat in Treating Patients with Metastatic Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11955, NCI-2012-01142, UCSF Protocol No. 11955, NCT01543763
Dasatinib and Ipilimumab in Treating Patients with Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-083, NCI-2012-01165, CDR0000737378, 9172, NCT01643278
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients with Gynecologic Cancers Undergoing Brachytherapy
Phase: Phase I
Type: Supportive care
Age: 19 and over
Trial IDs: GYN0005, NCI-2013-02400, 5136, NCT02058550
18F-FDG PET/CT before Surgery in Mapping Lymph Nodes in Patients with Stage IB Cervical Cancer or High-Grade Endometrial Cancer
Phase: Phase I
Type: Diagnostic
Age: 18 to 75
Trial IDs: 14-222, NCI-2014-02552, NCT02285192
NY-ESO-1-Specific T Cells in Treating Patients with Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2721.00, NCI-2014-02154, 2721, 2721.00A, NCT02319824
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 11-02-064, NCI-2013-01225, 10-089, NCT01367301
Proton Beam Radiation Therapy in Treating Patients with Uterine and Cervical Cancer with Regional Lymph Node Metastases
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 10-269, NCI-2011-00894, NCT01600040
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, and Urologic Cancers
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 08176, NCI-2013-00839, NCT01846520
Media Diversion in Improving Quality of Life in Patients with Recurrent Gynecologic Cancers Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: UW13037, NCI-2013-01284, 2013-0618, 2013-0618-CP004, 2013-0618-CR002, NCT01901835
Cognitive-Behavioral Intervention in Treating Worry, Uncertainty, and Insomnia in Cancer Survivors
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: OSU-09096, NCI-2012-02879, 2010C0004, NCT01929720
Patient-Controlled Cognitive-Behavioral Intervention in Reducing Pain, Fatigue, and Sleep Disturbance in Patients With Metastatic or Recurrent Lung, Breast, Colorectal, Prostate, or Gynecological Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: OS11322, NCI-2013-02325, 2013-0733, NCT01954420
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-03-096, NCI-2013-01364, 13-014, NCT01958580
Surgery and Chemotherapy with or without Chemotherapy after Surgery in Treating Patients with Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Phase: No phase specified
Type: Tissue collection/Repository, Treatment
Age: 18 and older
Trial IDs: 12316, NCI-2013-01948, 108303, 116613, NCT01970722
Start Over